Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Joshua_Bilenker
|
| gptkbp:focus |
precision medicine
drug discovery |
| gptkbp:foundedYear |
2021
|
| gptkbp:founder |
gptkb:Joshua_Bilenker
|
| gptkbp:fundedBy |
$273 million
|
| gptkbp:headquartersLocation |
gptkb:Stamford,_Connecticut
|
| https://www.w3.org/2000/01/rdf-schema#label |
Treeline Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:BVF_Partners
gptkb:OrbiMed gptkb:RA_Capital_Management gptkb:Wellington_Management gptkb:Boxer_Capital gptkb:Surveyor_Capital gptkb:Access_Biotechnology |
| gptkbp:website |
https://www.treelinebiosciences.com/
|
| gptkbp:bfsParent |
gptkb:Third_Rock_Ventures
|
| gptkbp:bfsLayer |
6
|